Table 2.
Overview of the reviewed studies comparing the pharmacologic choices for conscious sedation.
| Authors | Year | Location | Purpose | Type of source | Summary points |
|---|---|---|---|---|---|
| Kronfli et al. [32] | 2021 | USA | Comparing dexmedetomidine and propofol in TAVR procedures | Retrospective cohort study | (i) There was no significant differences in in-hospital outcomes, 30-day outcomes, or total cost of the patient's hospitalization between the groups |
|
| |||||
| Zhao et al. [33] | 2022 | USA | Comparing ketamine and nonketamine drugs in TAVR procedures | Retrospective cohort study | (i) Ketamine had statistically lower 30-day mortality and lower intraoperative cardiac arrest |
| (ii) There was no statistical difference in postoperative stroke, intraoperative conversion to general anesthesia, postoperative delirium, need for permanent pacemaker implantation, perivalvular leak, and length of stay between the groups | |||||